Warfarin combined with low-dose aspirin in MI did not provide clinical benefit beyond that of aspirin alone

Oh, Vernon M.
September 2002
ACP Journal Club;Sep/Oct2002, Vol. 137 Issue 2, p47
Academic Journal
Compares the effect of warfarin combined with aspirin and aspirin alone on patients who have survived an acute myocardial infarction. Study design and main outcome measures; Intracranial hemorrhage rates; Information on bleeding occurrences in combination therapy.


Related Articles

  • MEDICINE IN THE NEWS. Kaplan, Deborah // Patient Care for the Nurse Practitioner;Nov2005, Vol. 8 Issue 11, p10 

    The article provides information from studies on warfarin use. Warfarin plus aspirin was associated with lower annual recurrence rate of myocardial infarction, annual incidence rate of ischemic stroke, and need for revascularization, compared with aspirin alone. Investigators of a study of...

  • Choosing Anticoagulation or Aspirin After Heart Attack. Zepf, Bill // American Family Physician;3/15/2003, Vol. 67 Issue 6, p1349 

    Discusses the study 'Warfarin, Aspirin, or Both After Myocardial Infarction,' by M. Hurlen et al., from the September 26, 2002 issue of the 'New England Journal of Medicine.'

  • Warfarin, Aspirin, or Both after Myocardial Infarction. Hurlen, Mette; Abdelnoor, Michael; Smith, Pål; Erikssen, Jan; Arnesen, Harald // New England Journal of Medicine;9/26/2002, Vol. 347 Issue 13, p969 

    Background: The role of antithrombotic therapy in secondary prevention after myocardial infarction is well established. Although the available literature suggests that warfarin is superior to aspirin, aspirin is currently the more widely used drug. We studied the efficacy and safety of warfarin,...

  • Dissolution of an apical thrombus by apixaban in a patient with old anteroseptal myocardial infarction. Yanıkoğlu, Atakan; Altıntaş, Mehmet Sait; Ekinözü, İsmail // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Aug2015, Vol. 15 Issue 8, p671 

    The article presents a case study of a 55-year-male presented with follow-up for myocardial infarction (MI) with no atrial fibrillation (AF). Topics discussed include gastric bleeding due to use of warfarin and acetylsalicylate, decision for giving novel oral anticoagulant (NOAC) Apixaban and...

  • No benefit to adding warfarin to aspirin after heart attack. Blakely, Pamela F.; King, Valerie J. // Journal of Family Practice;Jun2002, Vol. 51 Issue 6, p518 

    The article deals with a study which examines whether adding warfarin to aspirin is more effective in preventing subsequent cardiovascular events. It provides details of the population studied and the study design and validity. All-cause mortality was the primary outcome measured while...

  • Warfarin, acetylsalicylic acid or both? Hoey, John // CMAJ: Canadian Medical Association Journal;10/29/2002, Vol. 167 Issue 9, p1036 

    Examines drug therapies used in treatment of myocardial infarction including warfarin, acetylsalicylic acid (ASA), or aspirin, or both. Results of tests involving patients in all three drug therapies; Conclusions based on results show mortality across all three therapies were identical.

  • An aspirin/warfarin cocktail prevents MIs. Cerrato, Paul L. // RN;Apr98, Vol. 61 Issue 4, p78 

    States that according to a large scale British trial which was conducted, the combination of aspirin and warfarin can reduce the risk of a first myocardial infarction by a third. Information on the reluctance by clinicians to combine the drugs; Details on the nature of drugs to cause bleeding.

  • Aspirin for all over 50 revisited. Elwood, Peter; Morgan, Gareth // Heart;Nov2008, Vol. 94 Issue 11, p1364 

    The article reports on a study of the risks of aspirin prophylaxis among diabetic patients with ages ranging between 30 to 74 years. It states that vascular risk of aspirin prophylaxis is estimated to people whose age is 48 years old for men and 57 years old for women. It also mentions that...

  • Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force. Hayden, Michael; Pignone, Michael; Phillips, Christopher; Mulrow, Cynthia // Annals of Internal Medicine;1/15/2002, Vol. 136 Issue 2, p161 

    Examines the pros and cons of aspirin in preventing cardiovascular diseases in the U.S. Reduction in the risk of nonfatal myocardial infarction; Tendency to cause hemorrhagic strokes; Efficacy of aspirin chemoprevention in patients with coronary heart diseases.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics